As we observe Endometriosis Awareness Month in March, let us take a look at 7 biotech companies advancing promising ...

Endometrial organoids, 3D cell cultures mimicking the endometrium, offer new opportunities in endometriosis research. These ...

They’re trending across social media as anti-aging miracles—but experts aren’t convinced. Here’s what science (and ...

Relugolix-estradiol-norethisterone (also known as relugolix combination therapy or Ryeqo), is the “first of its kind” daily ...

Here, they discuss the challenges of determining health risks associated with low-dose chemical exposures Nearly 500 years ...

Three women explain why going through menopause was a moment of reckoning that made them decide to leave their partners and ...

A transformational new pill for treating endometriosis has been approved for use on the NHS across England. The new tablet, ...

Endometriosis affects millions of people - and this new breakthrough treatment could be a game-changer for some ...

When Arianna began going through menopause in 2020, something inside her shifted. A seventh-generation Mormon, Arianna had been married to her husband for decades and had grown accustomed to keeping ...

Reference: Higginbotham JA, Abt JG, Teich RH, Dearman JJ, Lintz T, Morón JA. Estradiol protects against pain-facilitated fentanyl use via suppression of opioid-evoked dopamine activity in males.

Discover the newly approved endometriosis pill, Ryeqo, by NHS England, an innovative treatment offering hope to women ...